Good point. You would think only a matter of time until the market catches wind. A biotech company with revenue scale, an actual commercial presence in the holy grail of the US, and with profitability forecast within the next 3-5 years. This is the same market that values IMU at 2.7b (not diluted) without a single cent of product sold.
IPO - Pacific Edge Limited - 23 September 2021 #, page-13
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PEB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.32M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 102 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 100010 | 2 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| PEB (ASX) Chart |
Day chart unavailable